Statistics

Total Visits

Views
Glioblastoma TCGA mesenchymal and IGS 23 tumors are identifiable by immunohistochemistry and have an immune-phenotype indicating potential benefit from immunotherapy 119

Total Visits Per Month

November 2023 December 2023 January 2024 February 2024 March 2024 April 2024 May 2024
Glioblastoma TCGA mesenchymal and IGS 23 tumors are identifiable by immunohistochemistry and have an immune-phenotype indicating potential benefit from immunotherapy 4 8 2 1 2 2 0

File Visits

Views
Carrato_ccr_glio.pdf 235

Top country views

Views
United States 70
Spain 29
Germany 5
Sweden 3
Russia 2
Brazil 1
France 1
Hong Kong 1
India 1
Iran 1

Top cities views

Views
San Ramon 26
Barcelona 9
Mountain View 7
Fremont 6
Rochester 4
Arteixo 3
Ashburn 3
Cambridge 3
Redwood City 3
San Diego 3

Search DSpace


Advanced Search

Browse

My Account

Statistics

In collaboration with Compliant to Partaking